The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. (Q48185073)

9 February 2018

title

The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. (English)

1 reference

9 February 2018

Erratum: Corrigendum: The gene encoding phosphodiesterase 4D confers risk of ischemic stroke

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NG0505-555A

author

Vilmundur Gudnason

24

1 reference

9 February 2018

Daníel F. Guðbjartsson

28

1 reference

9 February 2018

Gudmar Thorleifsson

2

object named as

Gudmar Thorleifsson

1 reference

9 February 2018

31

Kari Stefansson

1 reference

9 February 2018

Jeffrey Gulcher

32

object named as

Jeffrey R Gulcher

1 reference

9 February 2018

author name string

Solveig Gretarsdottir

1

1 reference

9 February 2018

Sigridur Th Reynisdottir

3

1 reference

9 February 2018

Andrei Manolescu

4

1 reference

9 February 2018

Sif Jonsdottir

5

1 reference

9 February 2018

Thorbjörg Jonsdottir

6

1 reference

9 February 2018

Thorunn Gudmundsdottir

7

1 reference

9 February 2018

Sigrun M Bjarnadottir

8

1 reference

9 February 2018

Olafur B Einarsson

9

1 reference

9 February 2018

Herdis M Gudjonsdottir

10

1 reference

9 February 2018

Malcolm Hawkins

11

1 reference

9 February 2018

Gudmundur Gudmundsson

12

1 reference

9 February 2018

Hrefna Gudmundsdottir

13

1 reference

9 February 2018

Hjalti Andrason

14

1 reference

9 February 2018

Asta S Gudmundsdottir

15

1 reference

9 February 2018

Matthildur Sigurdardottir

16

1 reference

9 February 2018

Thomas T Chou

17

1 reference

9 February 2018

Joseph Nahmias

18

1 reference

9 February 2018

Shyamali Goss

19

1 reference

9 February 2018

Sigurlaug Sveinbjörnsdottir

20

1 reference

9 February 2018

Einar M Valdimarsson

21

1 reference

9 February 2018

Finnbogi Jakobsson

22

1 reference

9 February 2018

Uggi Agnarsson

23

1 reference

9 February 2018

Gudmundur Thorgeirsson

25

1 reference

9 February 2018

Jurgen Fingerle

26

1 reference

9 February 2018

Mark Gurney

27

1 reference

9 February 2018

Michael L Frigge

29

1 reference

9 February 2018

Augustine Kong

30

1 reference

9 February 2018

language of work or name

English

0 references

publication date

21 September 2003

1 reference

9 February 2018

published in

Nature Genetics

1 reference

9 February 2018

volume

35

1 reference

9 February 2018

page(s)

131-138

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/ng1245

exact match

0 references

cites work

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors

1 reference

21 January 2018

Epidemiology of stroke

1 reference

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

Lacunar strokes and infarcts: a review

21 January 2018

1 reference

Genetics and ischaemic stroke

21 January 2018

1 reference

Stroke prevention: management of modifiable vascular risk factors

21 January 2018

1 reference

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12

21 January 2018

1 reference

Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia

21 January 2018

1 reference

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

21 January 2018

1 reference

Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21

21 January 2018

1 reference

Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas

21 January 2018

1 reference

Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1)

21 January 2018

1 reference

Localization of a susceptibility gene for common forms of stroke to 5q12

21 January 2018

1 reference

A haplotype-based 'haplotype relative risk' approach to detecting allelic associations.

21 January 2018

1 reference

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization

21 January 2018

1 reference

Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses

21 January 2018

1 reference

Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects

21 January 2018

1 reference

Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells

21 January 2018

1 reference

8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo

21 January 2018

1 reference

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

21 January 2018

1 reference

Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter

21 January 2018

1 reference

Protection of privacy by third-party encryption in genetic research in Iceland

21 January 2018

1 reference

Fluorescence energy transfer detection as a homogeneous DNA diagnostic method

21 January 2018

1 reference

The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling

21 January 2018

1 reference

Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations

21 January 2018

1 reference

7 January 2021

Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of

1 reference

7 January 2021

Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expr

1 reference

7 January 2021

Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK).

1 reference

7 January 2021

Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation

1 reference

7 January 2021

Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels

1 reference

7 January 2021

Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties

1 reference

7 January 2021

Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors

1 reference

7 January 2021

Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury

1 reference

7 January 2021

Linkage disequilibrium in finite populations

1 reference

7 January 2021

Identifiers

DOI

10.1038/NG1245

1 reference

9 February 2018

PubMed ID

14517540

1 reference

9 February 2018